tiprankstipranks
Innovent Biologics (IVBXF)
OTHER OTC:IVBXF
Holding IVBXF?
Track your performance easily

Innovent Biologics (IVBXF) Cash flow

31 Followers

Innovent Biologics Cash Flow

IVBXF's free cash flow for Q2 2022 was ¥―. For the 2022 fiscal year, IVBXF's free cash flow was decreased by ¥-2.79B and operating cash flow was ¥―. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 21Dec 20Dec 19Dec 18Dec 17
Operating Cash Flow
-¥ -2.02B¥ -307.69M¥ -1.66B¥ -1.01B¥ -492.27M
Investing Cash Flow
-¥ -2.70B¥ -5.18B¥ -2.57B¥ 855.23M¥ -349.46M
Financing Cash Flow
-¥ 5.00B¥ 4.91B¥ 2.11B¥ 4.43B¥ 89.41M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
-¥ 1.36B¥ 1.28B¥ 2.43B¥ 4.52B¥ 183.76M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
-¥ 3.95B¥ 4.66B¥ 2.17B¥ 4.32B¥ 104.25M
Issuance Of Debt
-¥ 1.46B¥ 372.18M¥ 43.00M¥ 287.00M¥ 10.00M
Repayment Of Debt
-¥ -255.00M¥ -17.00M¥ -10.00M¥ -5.00M¥ 0.00
Free Cash Flow
-¥ -3.87B¥ -1.08B¥ -2.03B¥ -1.32B¥ -583.24M
Domestic Sales
------
Foreign Sales
------
Currency in CNY

Innovent Biologics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis